| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,357 | 17,971 | 12,462 | 13,929 | | Cost of Revenue |
-
| 40,937 |
-
| (9,674) | | | Gross Profit | 20,357 | (22,966) | 12,462 | 23,603 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 19,712 | (23,447) | 13,325 | 21,537 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,247 | 1,104 | 602 | 398 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (602) | (623) | (1,465) | 1,668 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 282 | 103 | 190 | 304 | | Earnings Before Interest And Taxes | (320) | (520) | (1,275) | 1,972 | | Interest Expense | 6 | 7 | 7 | 9 | | Income Before Tax | (326) | (527) | (1,282) | 1,963 | | Income Tax Expense | 708 | 520 | 502 | 1,073 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,034) | (1,047) | (1,784) | 890 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,034) | (1,047) | (1,784) | 890 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,034) | ($1,047) | ($1,784) | $890 |
|
0.51% Nasdaq 
Income Statement
